Mapping the intercellular adhesion molecule-1 and -2 binding site on the inserted domain of leukocyte...

Area of Science:

• Immunology
• Molecular Biology
• Structural Biology

Background:

• Leukocyte function-associated antigen-1 (LFA-1) is a crucial integrin involved in cell-cell adhesion.
• Intercellular adhesion molecules (ICAM-1 and -2) are key ligands for LFA-1, mediating immune cell interactions.
• Understanding the LFA-1 I-domain binding interface is critical for immune response modulation.

Purpose of the Study:

• To define the specific amino acid residues within the LFA-1 I-domain responsible for binding to ICAM-1 and ICAM-2.
• To elucidate the structural basis of LFA-1-ICAM interactions.
• To develop a molecular model of the LFA-1 I-domain/ICAM-1 interface.

Main Methods:

• Extensive site-directed mutagenesis of the LFA-1 I-domain (CD11a).
• Assessing LFA-1 binding to ICAM-1 and ICAM-2 using quantitative binding assays.
• Antibody-based assays to confirm I-domain structure integrity post-mutation.
• Computational modeling using mutagenesis data and ICAM-2 crystal structure.

Main Results:

• Specific mutations (Leu-205, Glu-241) completely abolished LFA-1 binding to both ICAM-1 and ICAM-2.
• Thr-243 mutation significantly reduced binding to ICAM-2 and abolished it for ICAM-1.
• Mutations at Glu-146, His-264, and Glu-293 showed varying degrees of binding reduction.
• Lys-263 mutation preferentially abolished LFA-1 binding to ICAM-2.
• A model of the LFA-1 I-domain interface with ICAM-1 was generated, and residues for ICAM-2 binding were mapped.

Conclusions:

• Mutagenic analysis successfully identified critical residues in the LFA-1 I-domain for ICAM-1 and ICAM-2 binding.
• The study provides a detailed molecular understanding of the LFA-1/ICAM interaction interface.
• The generated model and mapped residues offer insights for targeted therapeutic interventions in immune-related diseases.